Cargando…
Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration
FLT3-ITD–mediated leukemogenesis is associated with increased expression of oncogenic PIM serine/threonine kinases. To dissect their role in FLT3-ITD–mediated transformation, we performed bone marrow reconstitution assays. Unexpectedly, FLT3-ITD cells deficient for PIM1 failed to reconstitute lethal...
Autores principales: | Grundler, Rebekka, Brault, Laurent, Gasser, Christelle, Bullock, Alex N., Dechow, Tobias, Woetzel, Sabine, Pogacic, Vanda, Villa, Antonello, Ehret, Sabine, Berridge, Georgina, Spoo, Anke, Dierks, Christine, Biondi, Andrea, Knapp, Stefan, Duyster, Justus, Schwaller, Juerg |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737164/ https://www.ncbi.nlm.nih.gov/pubmed/19687226 http://dx.doi.org/10.1084/jem.20082074 |
Ejemplares similares
-
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia
por: Green, Alexa S., et al.
Publicado: (2015) -
The PIM family of oncoproteins: Small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets
por: Saurabh, Kumar, et al.
Publicado: (2014) -
The serine‐threonine kinase PIM3 is an aldosterone‐regulated protein in the distal nephron
por: Spirli, Alessia, et al.
Publicado: (2019) -
PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma
por: Brault, L, et al.
Publicado: (2012) -
Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress
por: Doshi, Kshama A., et al.
Publicado: (2016)